- Location
- Sydmarken 11, Denmark
- Type
- Full-time
- Department
- IT
- Seniority
- Senior
- Experience
- 5+ years
- Education
- PhD
- Closing date
- Today
- Source
- Workday
Description
Does it excite you to transform cutting‑edge peptide science into patient‑ready injectable formulations, and do you have experience driving phase‑appropriate formulation from discovery to Phase 2, including fixed‑dose combinations? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Senior Drug Product Specialist, you will drive formulation development from research projects into Phase 2 with a strong focus on injectables in different formats and fixed-dose combinations. You will design robust formulations, define process and scale-up strategies, and ensure phase-appropriate control strategies that enable tox and clinical supplies. Close collaboration with contract manufacturing organizations and Regulatory Affairs will ensure strong alignment and timely delivery across activities.
We offer exciting responsibilities:
Lead formulation development for injectables from early research to Phase 2, including design of experiments (DoE), excipient and compatibility assessments, stability strategies, and fixed-dose combination development
Design drug product manufacturing processes and define scale-up strategies aligned with phase-appropriate controls
Plan and, when relevant, execute lab-scale formulation experiments, characterization, and troubleshooting
Provide input to drug product manufacturing plans covering purpose, timing, and batch size to secure clinical supply readiness
Lead product and process risk assessments in collaboration with contract manufacturing organizations (CMOs)
Define and execute primary packaging selection
Your profile
A structured, collaborative specialist who brings scientific rigor to formulation challenges and balances speed with quality in early development. Communicates clearly across functions and maintains focus on patient needs, compliance, and timelines.
MSc/PhD in chemistry, biochemistry, pharmaceutical sciences, or a related field
Minimum 5 years of experience in formulation development for peptide-based medicines up to Phase 2
Experience with fixed-dose combinations
Experience with Good Manufacturing Practice (GMP) and regulatory aspects of Chemistry, Manufacturing and Controls (CMC) work
Practical experience with drug product manufacturing and tech transfer, including outsourcing to contract manufacturing organizations (CMOs)
Motivation to work hands-on in the laboratory when needed
Your new team
You will join Pharmaceutical Development within Research, working closely with colleagues across Development, Quality, Clinical Supply, and external partners. The team is characterized by collaboration, accountability, and a shared commitment to bringing high-quality medicines to patients.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture. Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than August 7th, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying. Please note that due to vacation period, delayed responses may occur.
For further information, please contact VP Head of Pharmaceutical Development, Lise Giehm and [email protected].
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma's business and activities, please visit www.zealandpharma.com.
#LI-Onsite
